Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Could the Silver Price Really Hit US$100 per Ounce? (Updated 2024)

Top 10 Copper-producing Companies (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Top 10 Countries for Natural Gas Production (Updated 2024)

Where Does Tesla Get its Lithium? (Updated 2024)

7 Biggest Lithium-mining Companies

Top 5 Canadian Uranium Stocks of 2024

11 Canadian Cryptocurrency ETFs (Updated 2024)

Hydrogen Stocks: 9 Biggest Companies

Trending Press Releases

Galan Increases Total Mineral Resource by 18% to 8.6Mt LCE @ 859mg/L Lithium

Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study

Health House Australia and Corporate Update

Significant Mineral Resource Upgrade for Project Iron Bear

Deep Drilling Hits Visible Gold Over 1km Deep Below Never Never Gold Deposit

Steppe Gold Enters Into Share Exchange Agreement to Acquire Boroo Gold and Agrees to Sell the Tres Cruces Oxide Project

More Press Releases
Trending Companies

Cyclone Metals

CLE:AU

Lancaster Resources

LCR:CC

Purpose Bitcoin ETF

BTCC:CA

Galan Lithium

GLN:AU
More Companies
Trending Reports

2024 Rare Earths Outlook: Australia Edition

2024 EV Market Outlook Report

2024 Gold Outlook: Australia Edition

2024 Lithium Market Outlook

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold
Copper
Uranium
Oil and Gas
Artificial Intelligence
Biotech
loader

Renovacor Inc.

NYSE:RCOR
Press Releases

Renovacor Inc is a preclinical stage gene therapy company developing a pipeline of innovative and proprietary AAV-based gene therapies for BAG3 gene mutation-associated diseases in areas of high unmet medical need. Its therapeutic focus is on cardiovascular disease, with a lead program in BAG3 mutation-associated dilated cardiomyopathy.

×